{"id":305625,"date":"2025-07-15T13:09:57","date_gmt":"2025-07-15T13:09:57","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/cvs-vs-walgreens-stock-2\/"},"modified":"2025-07-15T13:09:57","modified_gmt":"2025-07-15T13:09:57","slug":"cvs-vs-walgreens-stock","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/","title":{"rendered":"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\"><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":220418,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[25],"tags":[28,45,44],"class_list":["post-305625","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reviews","tag-investment","tag-stock","tag-strategy"],"acf":{"h1":"Tam Analiz: CVS ve Walgreens Hisse Senedi Kar\u015f\u0131la\u015ft\u0131rmas\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Tam Analiz: CVS ve Walgreens Hisse Senedi Kar\u015f\u0131la\u015ft\u0131rmas\u0131"},"description":"CVS ve Walgreens hisse performans\u0131, piyasa konumland\u0131rmas\u0131 ve gelecekteki g\u00f6r\u00fcn\u00fcm\u00fcn\u00fcn kapsaml\u0131 analizi \u2014 finans uzmanlar\u0131ndan bug\u00fcn mevcut olan uygulanabilir i\u00e7g\u00f6r\u00fcler.","description_source":{"label":"Description","type":"textarea","formatted_value":"CVS ve Walgreens hisse performans\u0131, piyasa konumland\u0131rmas\u0131 ve gelecekteki g\u00f6r\u00fcn\u00fcm\u00fcn\u00fcn kapsaml\u0131 analizi \u2014 finans uzmanlar\u0131ndan bug\u00fcn mevcut olan uygulanabilir i\u00e7g\u00f6r\u00fcler."},"intro":"CVS ve Walgreens aras\u0131nda se\u00e7im yapmak, eczane perakende ekonomisi, sa\u011fl\u0131k entegrasyon stratejileri ve rekabet\u00e7i konumland\u0131rman\u0131n derinlemesine analizini gerektirir. Bu ara\u015ft\u0131rma, bu eczane perakende devlerini kar\u015f\u0131la\u015ft\u0131ran yat\u0131r\u0131mc\u0131lar i\u00e7in performans \u00f6l\u00e7\u00fctlerini, b\u00fcy\u00fcme fakt\u00f6rlerini ve risk fakt\u00f6rlerini incelemektedir.","intro_source":{"label":"Intro","type":"text","formatted_value":"CVS ve Walgreens aras\u0131nda se\u00e7im yapmak, eczane perakende ekonomisi, sa\u011fl\u0131k entegrasyon stratejileri ve rekabet\u00e7i konumland\u0131rman\u0131n derinlemesine analizini gerektirir. Bu ara\u015ft\u0131rma, bu eczane perakende devlerini kar\u015f\u0131la\u015ft\u0131ran yat\u0131r\u0131mc\u0131lar i\u00e7in performans \u00f6l\u00e7\u00fctlerini, b\u00fcy\u00fcme fakt\u00f6rlerini ve risk fakt\u00f6rlerini incelemektedir."},"body_html":"<div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Rekabet\u00e7i Manzara: Perakende Eczac\u0131l\u0131kta CVS ve Walgreens Hisse Senetleri<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Eczane perakende yat\u0131r\u0131mlar\u0131, portf\u00f6y \u00e7e\u015fitlendirmesi i\u00e7in benzersiz sa\u011fl\u0131k hizmeti maruziyeti sunar. CVS ve Walgreens hisse senetlerini incelerken, yat\u0131r\u0131mc\u0131lar bu \u015firketlerin farkl\u0131 i\u015f modelleri, b\u00fcy\u00fcme yollar\u0131 ve pazar pozisyonlar\u0131 ile kapsaml\u0131 sa\u011fl\u0131k ekosistemlerini temsil etti\u011fini fark etmelidir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS, sigorta ve eczane fayda y\u00f6netimi yoluyla dikey entegrasyonu takip ederken, Walgreens uluslararas\u0131 geni\u015fleme ve stratejik ortakl\u0131klara vurgu yap\u0131yor\u2014temelde farkl\u0131 yat\u0131r\u0131m profilleri olu\u015fturuyor. Pocket Option analistleri, hedefe y\u00f6nelik yat\u0131r\u0131m i\u00e7g\u00f6r\u00fcleri sa\u011flamak i\u00e7in bu farkl\u0131l\u0131klar\u0131 izler.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Tarihsel Performans Analizi: Walgreens Hisse Senedi ve CVS Hisse Senedi<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens hisse senedi ve CVS hisse senedini do\u011fru bir \u015fekilde de\u011ferlendirmek i\u00e7in tarihsel performans verileri, her \u015firketin stratejik kararlar\u0131n\u0131 ve pazar uyumunu yans\u0131tan belirli fiyat trendlerini ortaya koyar.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Performans Metrikleri<\/th><th>CVS Health (CVS)<\/th><th>Walgreens Boots Alliance (WBA)<\/th><\/tr><\/thead><tbody><tr><td>5 Y\u0131ll\u0131k Hisse Senedi Performans\u0131<\/td><td>%12 art\u0131\u015f, %22 volatilite<\/td><td>%45 d\u00fc\u015f\u00fc\u015f, %30 volatilite<\/td><\/tr><tr><td>Temett\u00fc Verimi (G\u00fcncel)<\/td><td>%3.2<\/td><td>%4.8<\/td><\/tr><tr><td>F\/K Oran\u0131 (G\u00fcncel)<\/td><td>8.7x<\/td><td>6.9x<\/td><\/tr><tr><td>Gelir B\u00fcy\u00fcmesi (5 Y\u0131ll\u0131k Bile\u015fik Y\u0131ll\u0131k B\u00fcy\u00fcme Oran\u0131)<\/td><td>%8.9<\/td><td>%3.2<\/td><\/tr><tr><td>EBITDA Marj\u0131 (G\u00fcncel)<\/td><td>%6.8<\/td><td>%4.5<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS'nin 2018'de sa\u011fl\u0131k sigortac\u0131s\u0131 Aetna'y\u0131 69 milyar dolara sat\u0131n almas\u0131, bor\u00e7-EBITDA oran\u0131n\u0131 4.6x'e \u00e7\u0131kard\u0131 ancak y\u0131ll\u0131k 900+ milyon dolarl\u0131k sinerji sa\u011flayarak 3.0x'e d\u00fc\u015f\u00fcrd\u00fc ve hisse senedi performans\u0131n\u0131 istikrara kavu\u015fturdu. Buna kar\u015f\u0131l\u0131k, Walgreens yatay geni\u015flemeye odaklanarak WBA hisse de\u011fer art\u0131\u015f\u0131 i\u00e7in kar\u0131\u015f\u0131k sonu\u00e7lar elde etti.<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>Pazar D\u00f6ng\u00fcleri ve Eczane Hisse Senedi Performans\u0131<\/h3><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS ve Walgreens hisse senedi fiyatlar\u0131 ekonomik d\u00f6ng\u00fcler s\u0131ras\u0131nda \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131l\u0131k g\u00f6sterir, be\u015f y\u0131ll\u0131k beta katsay\u0131lar\u0131 s\u0131ras\u0131yla 0.75 ve 0.90 olup, pazar hareketlerine farkl\u0131 duyarl\u0131l\u0131k g\u00f6sterir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>2020 pazar d\u00fc\u015f\u00fc\u015f\u00fc s\u0131ras\u0131nda, CVS hisse senedi %14 d\u00fc\u015ferken Walgreens %28 d\u00fc\u015ft\u00fc, bu da CVS'nin eczane fayda y\u00f6netimi ve sigorta segmentlerindeki \u00e7e\u015fitlendirilmi\u015f gelir ak\u0131\u015flar\u0131ndan \u00fcst\u00fcn dayan\u0131kl\u0131l\u0131\u011f\u0131n\u0131 g\u00f6sterdi.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>\u0130\u015f Modeli Kar\u015f\u0131la\u015ft\u0131rmas\u0131: WBA ve CVS Hisse Senedi Temelleri<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Bu \u015firketlerin operasyonel stratejileri, gelir istikrar\u0131, marj profilleri ve b\u00fcy\u00fcme potansiyelini do\u011frudan etkiler\u2014WBA ve CVS hisse senedi yat\u0131r\u0131m de\u011ferini de\u011ferlendirirken anahtar fakt\u00f6rlerdir.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>\u0130\u015f Segmenti<\/th><th>CVS Health Yakla\u015f\u0131m\u0131<\/th><th>Walgreens Boots Alliance Yakla\u015f\u0131m\u0131<\/th><\/tr><\/thead><tbody><tr><td>Perakende Eczane<\/td><td>9,900 lokasyon, 1,100 MinuteClinic sitesi<\/td><td>9,000 ABD lokasyonu, 13,000+ k\u00fcresel<\/td><\/tr><tr><td>Sa\u011fl\u0131k Hizmetleri<\/td><td>Caremark PBM (105M+ hayat), Aetna (25M+ \u00fcye)<\/td><td>VillageMD hissesi (%55), CareCentrix sat\u0131n al\u0131m\u0131<\/td><\/tr><tr><td>Dijital Strateji<\/td><td>43M+ kullan\u0131c\u0131ya sahip entegre uygulama, ba\u011fl\u0131 kay\u0131tlar<\/td><td>myWalgreens platformu (92M \u00fcye), teslimat ortakl\u0131klar\u0131<\/td><\/tr><tr><td>Uluslararas\u0131 Varl\u0131k<\/td><td>Gelirin &lt;%2'si uluslararas\u0131 operasyonlardan<\/td><td>Gelirin ~%25'i uluslararas\u0131 pazarlardan<\/td><\/tr><tr><td>Bor\u00e7 Yap\u0131s\u0131<\/td><td>67.4 milyar dolar uzun vadeli bor\u00e7, 3.0x bor\u00e7-EBITDA oran\u0131<\/td><td>38.5 milyar dolar uzun vadeli bor\u00e7, 2.6x bor\u00e7-EBITDA oran\u0131<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS, 9,900 eczane lokasyonu, y\u0131ll\u0131k 2+ milyar re\u00e7ete i\u015fleyen Caremark PBM hizmetleri ve Aetna'n\u0131n 25+ milyon sigorta \u00fcyesini birle\u015ftirerek entegre bir sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131s\u0131 olarak faaliyet g\u00f6sterir. Bu entegrasyon 80+ milyar dolarl\u0131k sermaye gerektirdi ancak savunmac\u0131 gelir \u00f6zellikleri ve %15 \u00e7apraz sat\u0131\u015f b\u00fcy\u00fcme f\u0131rsatlar\u0131 yaratt\u0131.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens, tam sat\u0131n al\u0131mlar yerine VillageMD'ye 5.2 milyar dolar ve CareCentrix'e 330 milyon dolar yat\u0131r\u0131m yapt\u0131. Bu sermaye hafif strateji, bilan\u00e7o esnekli\u011fini korur ancak ortaklar\u0131n icras\u0131na ba\u011f\u0131ml\u0131l\u0131k yarat\u0131r, bu da nihayetinde WBA hisse performans\u0131n\u0131 etkiler.<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>Marj Yap\u0131s\u0131 ve Karl\u0131l\u0131k Kar\u015f\u0131la\u015ft\u0131rmas\u0131<\/h3><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option analistleri, rakipler aras\u0131nda belirgin marj profilleri belirler: CVS, PBM entegrasyon verimlilikleri sayesinde %5.3 i\u015fletme marjlar\u0131n\u0131 korurken, Walgreens'in %3.8 marjlar\u0131, \u00f6n ma\u011faza perakende ekonomilerine daha fazla maruz kalmay\u0131 yans\u0131t\u0131r.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Karl\u0131l\u0131k Metrikleri<\/th><th>CVS Health<\/th><th>Walgreens Boots Alliance<\/th><\/tr><\/thead><tbody><tr><td>Br\u00fct Marj<\/td><td>%18.9<\/td><td>%21.5<\/td><\/tr><tr><td>\u0130\u015fletme Marj\u0131<\/td><td>%5.3<\/td><td>%3.8<\/td><\/tr><tr><td>Net Kar Marj\u0131<\/td><td>%3.1<\/td><td>%2.2<\/td><\/tr><tr><td>Varl\u0131k Getirisi<\/td><td>%4.2<\/td><td>%2.5<\/td><\/tr><tr><td>\u00d6zsermaye Getirisi<\/td><td>%12.8<\/td><td>%9.6<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>CVS ve Walgreens Hisse Senedi G\u00f6r\u00fcn\u00fcm\u00fcn\u00fc Etkileyen Stratejik Giri\u015fimler<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Her iki \u015firket de i\u015f modellerini sa\u011fl\u0131k hizmeti bozulmas\u0131, dijital h\u0131zlanma ve de\u011fi\u015fen t\u00fcketici tercihlerini ele almak i\u00e7in d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor\u2014bu geli\u015fmeler do\u011frudan CVS ve Walgreens hisse senedi y\u00f6r\u00fcngelerini etkiliyor.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS, 900+ HealthHUB lokasyonunu geni\u015fletmek i\u00e7in 1.5 milyar dolar yat\u0131r\u0131m yapt\u0131, ma\u011fazalar\u0131 diyabet bak\u0131m\u0131, uyku apnesi de\u011ferlendirmesi ve flebotomi hizmetleri dahil olmak \u00fczere geni\u015fletilmi\u015f klinik hizmetler sunan sa\u011fl\u0131k destinasyonlar\u0131na d\u00f6n\u00fc\u015ft\u00fcrd\u00fc. Bu yenileme, %15 daha y\u00fcksek re\u00e7ete yakalama oranlar\u0131 ve %8 artan ma\u011faza trafi\u011fi sa\u011fl\u0131yor.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens, 2025 y\u0131l\u0131na kadar Walgreens ma\u011fazalar\u0131 ile birlikte 1,000 tam hizmet birinci basamak sa\u011fl\u0131k uygulamas\u0131 kurarak VillageMD'ye 5.2 milyar dolar taahh\u00fct etti. Bu ortakl\u0131k temelli yakla\u015f\u0131m, ba\u015flang\u0131\u00e7 sermaye gereksinimlerini azaltt\u0131 ancak uygulama hedeflerinin ka\u00e7\u0131r\u0131lmas\u0131n\u0131n ard\u0131ndan WBA hisse senedi oynakl\u0131\u011f\u0131n\u0131 art\u0131ran icra ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 getirdi.<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>CVS, 2+ milyon hayat\u0131 kapsayan risk bazl\u0131 s\u00f6zle\u015fmeleri g\u00fcvence alt\u0131na almak i\u00e7in entegre modelini kullanarak, %15 y\u0131ll\u0131k b\u00fcy\u00fcme projeksiyonlar\u0131 ile 250+ milyon dolar de\u011fer bazl\u0131 bak\u0131m geliri \u00fcretiyor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Walgreens, 9 \u00fclkede operasyonlar\u0131n\u0131 s\u00fcrd\u00fcrerek co\u011frafi \u00e7e\u015fitlilik yarat\u0131yor ancak 2023'te kazan\u00e7 oynakl\u0131\u011f\u0131n\u0131 %3.5 art\u0131ran d\u00f6viz \u00e7evirim etkileri getiriyor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Her iki \u015firket de geleneksel eczane hizmetlerinin \u00f6tesine ge\u00e7erek klinik hizmetlerini geni\u015fletiyor, CVS MinuteClinic ziyaretlerinde %22 y\u0131ll\u0131k b\u00fcy\u00fcme sa\u011flarken Walgreens VillageMD kar\u015f\u0131la\u015fmalar\u0131nda %17 b\u00fcy\u00fcme elde ediyor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Re\u00e7ete otomasyonu ve merkezi yerine getirme konusundaki teknoloji yat\u0131r\u0131mlar\u0131, CVS i\u00e7in i\u015f\u00e7ilik maliyetlerini %8-10, Walgreens i\u00e7in %6-8 oran\u0131nda azaltarak do\u011frudan marj profillerini iyile\u015ftiriyor.<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Finansal Sa\u011fl\u0131k: CVS ve WBA Hisse Senedi Temelleri<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Bilan\u00e7o g\u00fcc\u00fc, nakit ak\u0131\u015f\u0131 \u00fcretimi ve sermaye tahsis \u00f6ncelikleri, CVS ve WBA hisse senedi risk profillerini ve uzun vadeli de\u011fer art\u0131\u015f potansiyelini \u00f6nemli \u00f6l\u00e7\u00fcde etkiler.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Finansal Metrik<\/th><th>CVS Health<\/th><th>Walgreens Boots Alliance<\/th><\/tr><\/thead><tbody><tr><td>Bor\u00e7-EBITDA Oran\u0131<\/td><td>3.0x (2018'de 4.6x'den d\u00fc\u015ft\u00fc)<\/td><td>2.6x (2020'de 1.9x'den artt\u0131)<\/td><\/tr><tr><td>Serbest Nakit Ak\u0131\u015f\u0131<\/td><td>Y\u0131ll\u0131k 12.5 milyar dolar<\/td><td>Y\u0131ll\u0131k 3.8 milyar dolar<\/td><\/tr><tr><td>Temett\u00fc Da\u011f\u0131t\u0131m Oran\u0131<\/td><td>%32<\/td><td>%42<\/td><\/tr><tr><td>Sermaye Harcamas\u0131<\/td><td>2.8 milyar dolar (%1.8 gelir)<\/td><td>1.7 milyar dolar (%2.1 gelir)<\/td><\/tr><tr><td>Faiz Kar\u015f\u0131lama Oran\u0131<\/td><td>8.2x<\/td><td>6.1x<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS'nin 67.4 milyar dolarl\u0131k uzun vadeli borcu, Aetna sat\u0131n al\u0131m\u0131ndan bu yana %12 azald\u0131 ve y\u0131ll\u0131k 12.5 milyar dolar serbest nakit ak\u0131\u015f\u0131 \u00fcreterek hem bor\u00e7 hizmeti hem de %3.2 temett\u00fc verimi yoluyla hissedar getirilerini destekliyor.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens, sa\u011fl\u0131k yat\u0131r\u0131mlar\u0131n\u0131 finanse etmek i\u00e7in kald\u0131ra\u00e7 oran\u0131n\u0131 1.9x'den 2.6x bor\u00e7-EBITDA'ya \u00e7\u0131kard\u0131 ve temett\u00fc aristokrat stat\u00fcs\u00fcn\u00fc korudu. Bu sermaye tahsis stratejisi, WBA'n\u0131n temett\u00fc kar\u015f\u0131lama oran\u0131n\u0131n \u00fc\u00e7 y\u0131l i\u00e7inde 2.4x'den 1.8x'e d\u00fc\u015fmesiyle ilgili endi\u015feleri art\u0131r\u0131yor.<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>Sermaye Tahsis \u00d6ncelikleri ve Hissedar Getirileri<\/h3><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Farkl\u0131 sermaye tahsis yakla\u015f\u0131mlar\u0131, farkl\u0131 hissedar getiri profilleri yarat\u0131r. CVS, Aetna sat\u0131n al\u0131m\u0131n\u0131n ard\u0131ndan \u00fc\u00e7 y\u0131l boyunca temett\u00fc art\u0131\u015flar\u0131n\u0131 ge\u00e7ici olarak ask\u0131ya ald\u0131 ancak 2022'de %10 y\u0131ll\u0131k temett\u00fc b\u00fcy\u00fcmesine devam etti ve 10 milyar dolarl\u0131k hisse geri al\u0131m program\u0131 ba\u015flatt\u0131.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens, \u015fu anda %4.8 getiri sa\u011flayan 47 y\u0131l boyunca temett\u00fc art\u0131\u015flar\u0131n\u0131 s\u00fcrd\u00fcrd\u00fc. Ancak, bu taahh\u00fct stratejik esnekli\u011fi k\u0131s\u0131tl\u0131yor, \u015firketin tarihi de\u011ferleme d\u00fc\u015f\u00fck seviyelerinde i\u015flem g\u00f6rmesine ra\u011fmen s\u0131n\u0131rl\u0131 1 milyar dolarl\u0131k hisse geri al\u0131m program\u0131 ile kan\u0131tland\u0131\u011f\u0131 gibi.<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>CVS, sa\u011fl\u0131k hizmeti geni\u015flemesinde stratejik yat\u0131r\u0131mlara y\u0131ll\u0131k 2.8 milyar dolar tahsis ediyor, HealthHUB yenilemeleri lokasyon ba\u015f\u0131na 450,000 dolara mal oluyor ancak %18 ROI sa\u011fl\u0131yor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Walgreens, 5.2 milyar dolarl\u0131k VillageMD yat\u0131r\u0131m\u0131n\u0131n %65'ini ABD operasyonlar\u0131na y\u00f6nlendirdi, geri kalan\u0131 ise \u0130ngiltere ve Almanya'daki uluslararas\u0131 klinik modellerini destekliyor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Her iki \u015firket de otomasyona yat\u0131r\u0131m yap\u0131yor, CVS'nin 600 milyon dolarl\u0131k merkezi yerine getirme merkezleri re\u00e7ete hacminin %50'sini i\u015fleyerek da\u011f\u0131t\u0131m maliyetlerini %15 azalt\u0131yor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse geri al\u0131m faaliyeti \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131l\u0131k g\u00f6steriyor: CVS, 2022'den bu yana 3.5 milyar dolarl\u0131k hisse geri ald\u0131, Walgreens ise daha b\u00fcy\u00fck de\u011ferleme indirimlerine ra\u011fmen sadece 500 milyon dolarl\u0131k geri al\u0131m yapt\u0131.<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>D\u00fczenleyici Ortam\u0131n Walgreens ve CVS Hisse Senedi Performans\u0131na Etkisi<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>D\u00fczenleyici geli\u015fmeler, eczane operasyonlar\u0131n\u0131, sa\u011fl\u0131k hizmeti sunum modellerini ve nihayetinde Walgreens ve CVS hisse senedi performans y\u00f6r\u00fcngelerini do\u011frudan etkiler.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>D\u00fczenleyici Fakt\u00f6r<\/th><th>CVS Health Etkisi<\/th><th>Walgreens Boots Alliance Etkisi<\/th><\/tr><\/thead><tbody><tr><td>\u0130la\u00e7 Fiyatland\u0131rma Reformlar\u0131<\/td><td>%1.8 EBITDA etkisi, %2.2 Aetna faydas\u0131 ile dengeleniyor<\/td><td>%2.5 EBITDA etkisi, s\u0131n\u0131rl\u0131 dengeleyici fakt\u00f6rler<\/td><\/tr><tr><td>Sa\u011fl\u0131k Sigortas\u0131 Geni\u015flemesi<\/td><td>%3.5 gelir f\u0131rsat\u0131 Aetna kayd\u0131 ile<\/td><td>%1.7 re\u00e7ete hacmi art\u0131\u015f potansiyeli<\/td><\/tr><tr><td>Eczane Geri \u00d6demesi<\/td><td>%1.5 marj etkisi, k\u0131smen PBM operasyonlar\u0131 taraf\u0131ndan absorbe ediliyor<\/td><td>%2.1 marj etkisi, do\u011frudan P&amp;L maruziyeti<\/td><\/tr><tr><td>Uluslararas\u0131 D\u00fczenlemeler<\/td><td>&lt;%0.5 etki, s\u0131n\u0131rl\u0131 uluslararas\u0131 maruziyet<\/td><td>%1.2 etki, \u0130ngiltere NHS geri \u00f6deme de\u011fi\u015fikliklerinden<\/td><\/tr><tr><td>Antitr\u00f6st \u0130nceleme<\/td><td>Dikey entegrasyon i\u00e7in potansiyel elden \u00e7\u0131karma gereklilikleri<\/td><td>S\u0131n\u0131rl\u0131 dikey konsolidasyon nedeniyle daha d\u00fc\u015f\u00fck risk profili<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>2022 Enflasyon Azaltma Yasas\u0131'n\u0131n Medicare ila\u00e7 fiyat\u0131 m\u00fczakere h\u00fck\u00fcmleri, her iki \u015firketi farkl\u0131 \u015fekilde etkiler: CVS, Aetna Medicare planlar\u0131 arac\u0131l\u0131\u011f\u0131yla fayda sa\u011flayabilirken, PBM \u015feffafl\u0131k gereklilikleriyle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131rken, Walgreens %1.5-2.0 eczane marj s\u0131k\u0131\u015fmas\u0131 tahminleriyle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131yor.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens'in uluslararas\u0131 operasyonlar\u0131, \u0130ngiltere pazar\u0131nda Boots eczane marjlar\u0131n\u0131 2023'te 120 baz puan azaltan NHS geri \u00f6deme bask\u0131lar\u0131 dahil olmak \u00fczere \u00e7e\u015fitli d\u00fczenleyici \u00e7er\u00e7evelere maruz kal\u0131yor. CVS'nin yerel odaklanmas\u0131, uluslararas\u0131 d\u00fczenleyici maruziyeti s\u0131n\u0131rlar ancak ABD sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fikliklerinde riski yo\u011funla\u015ft\u0131r\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Yat\u0131r\u0131m Tezi: CVS ve Walgreens Hisse Senedi \u00dczerine Analist Perspektifi<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Profesyonel yat\u0131r\u0131mc\u0131lar, her \u015firket i\u00e7in stratejik icra, konumland\u0131rma ve sa\u011fl\u0131k sekt\u00f6r\u00fc trendlerine dayal\u0131 olarak farkl\u0131 yat\u0131r\u0131m tezleri geli\u015ftirir. Pocket Option piyasa analistleri, her hissenin yat\u0131r\u0131m de\u011ferini \u015fekillendiren anahtar fakt\u00f6rleri belirlemi\u015ftir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>CVS Health \u0130\u00e7in Bo\u011fa Durumu<\/h3><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS bo\u011falar\u0131, Aetna entegrasyonundan elde edilen y\u0131ll\u0131k 900+ milyon dolarl\u0131k sinerji yakalama ba\u015far\u0131s\u0131n\u0131, ba\u015flang\u0131\u00e7 hedeflerini %20 a\u015farak 2024'e kadar 500+ milyon dolarl\u0131k ek gelir \u00fcretecek HealthHUB lokasyonlar\u0131n\u0131 geni\u015fletmeyi vurgular.<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>MinuteClinic ve HealthHUB lokasyonlar\u0131, %12 daha y\u00fcksek re\u00e7ete yakalama oranlar\u0131 sa\u011flarken, \u00f6n ma\u011faza al\u0131\u015fveri\u015flerini %8 art\u0131rarak de\u011ferli \u00e7apraz sat\u0131\u015f f\u0131rsatlar\u0131 yarat\u0131yor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Dijital sa\u011fl\u0131k giri\u015fimleri, 43+ milyon uygulama kullan\u0131c\u0131s\u0131n\u0131 y\u00fcz y\u00fcze deneyimlerle ba\u011flayarak, %22 daha y\u00fcksek ila\u00e7 uyumu ve %15 artan re\u00e7ete yenilemeleri sa\u011fl\u0131yor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Bor\u00e7 azalt\u0131m\u0131, finansal esnekli\u011fi g\u00fc\u00e7lendirdi, y\u0131ll\u0131k 12.5 milyar dolar serbest nakit ak\u0131\u015f\u0131, hem %3.2 temett\u00fc verimini hem de 10 milyar dolarl\u0131k hisse geri al\u0131m yetkisini destekliyor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>De\u011fer bazl\u0131 bak\u0131m giri\u015fimleri, art\u0131k 2+ milyon hayat\u0131 kaps\u0131yor, CVS'yi sa\u011fl\u0131k geri \u00f6demesinin hizmet ba\u015f\u0131na \u00fccret modelinden sonu\u00e7 bazl\u0131 modellere ge\u00e7i\u015fiyle avantajl\u0131 bir konuma getiriyor.<\/li><\/ul><\/div><div class='po-container po-container_width_article-sm'><h3 class='po-article-page__title'>Walgreens Boots Alliance \u0130\u00e7in Bo\u011fa Durumu<\/h3><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens bo\u011falar\u0131, \u015firketin 5 milyar dolarl\u0131k maliyet d\u00f6n\u00fc\u015f\u00fcm giri\u015fimlerini ve VillageMD arac\u0131l\u0131\u011f\u0131yla stratejik yeniden konumland\u0131rmas\u0131n\u0131 vurguluyor, hisse senedinin sekt\u00f6r\u00fcn 12.8x ortalamas\u0131na kar\u015f\u0131 6.9x ileri F\/K oran\u0131nda \u00f6nemli bir d\u00fc\u015f\u00fck de\u011ferleme g\u00f6sterdi\u011fine i\u015faret ediyor.<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>VillageMD ortakl\u0131\u011f\u0131, 2025 y\u0131l\u0131na kadar 1,000 birinci basamak sa\u011fl\u0131k lokasyonunu geni\u015fleterek, birlikte konumland\u0131r\u0131lm\u0131\u015f Walgreens eczanelerinde %30-35 ek re\u00e7ete b\u00fcy\u00fcmesi sa\u011fl\u0131yor.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Uluslararas\u0131 operasyonlar co\u011frafi \u00e7e\u015fitlilik sa\u011flar, \u0130ngiltere ve Alman pazarlar\u0131 ABD operasyonlar\u0131na g\u00f6re %1.2 daha y\u00fcksek eczane marjlar\u0131 sunar.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>2024'e kadar 3.5 milyar dolar tasarruf hedefleyen maliyet d\u00f6n\u00fc\u015f\u00fcm program\u0131, geri \u00f6deme bask\u0131lar\u0131na ra\u011fmen EBITDA marjlar\u0131n\u0131 80 baz puan art\u0131rarak zaten 2.2 milyar dolar sa\u011flad\u0131.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Mevcut de\u011ferleme, 0.25x fiyat-sat\u0131\u015f oran\u0131nda, CVS'nin 0.50x \u00e7arpan\u0131na g\u00f6re %50 indirim sunuyor, icra iyile\u015firse \u00f6nemli bir yukar\u0131 potansiyel sunuyor.<\/li><\/ul><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>De\u011ferleme Metrikleri<\/th><th>CVS Health<\/th><th>Walgreens Boots Alliance<\/th><th>Sekt\u00f6r Ortalamas\u0131<\/th><\/tr><\/thead><tbody><tr><td>\u0130leri F\/K Oran\u0131<\/td><td>8.7x<\/td><td>6.9x<\/td><td>12.8x<\/td><\/tr><tr><td>EV\/EBITDA \u00c7arpan\u0131<\/td><td>8.2x<\/td><td>6.1x<\/td><td>11.5x<\/td><\/tr><tr><td>Fiyat-Sat\u0131\u015f Oran\u0131<\/td><td>0.35x<\/td><td>0.25x<\/td><td>0.60x<\/td><\/tr><tr><td>Temett\u00fc Verimi<\/td><td>%3.2<\/td><td>%4.8<\/td><td>%2.2<\/td><\/tr><tr><td>PEG Oran\u0131<\/td><td>1.15<\/td><td>1.75<\/td><td>1.45<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Risk De\u011ferlendirmesi: WBA ve CVS Hisse Senedi Yat\u0131r\u0131m D\u00fc\u015f\u00fcnceleri<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Kapsaml\u0131 risk analizi, i\u015f kar\u0131\u015f\u0131m\u0131, stratejik icra ve finansal konumland\u0131rmaya dayal\u0131 olarak WBA ve CVS hisse senetleri aras\u0131nda belirgin savunmas\u0131zl\u0131k profilleri ortaya koyar.<\/p><\/div><div class='po-container po-container_width_article po-article-page__table'><div class='po-table'><table><thead><tr><th>Risk Kategorisi<\/th><th>CVS Health Maruziyeti<\/th><th>Walgreens Boots Alliance Maruziyeti<\/th><\/tr><\/thead><tbody><tr><td>Eczane Geri \u00d6demesi<\/td><td>Gelirin %42'si do\u011frudan maruz<\/td><td>Gelirin %68'i do\u011frudan maruz<\/td><\/tr><tr><td>Dijital Bozulma<\/td><td>Eczane hacminin %15'i potansiyel olarak savunmas\u0131z<\/td><td>Eczane hacminin %22'si potansiyel olarak savunmas\u0131z<\/td><\/tr><tr><td>Sa\u011fl\u0131k Politikas\u0131<\/td><td>Kar\u0131\u015f\u0131k: Aetna kapsama de\u011fi\u015fikliklerine maruz<\/td><td>S\u0131n\u0131rl\u0131: \u00d6ncelikle eczane kanallar\u0131 arac\u0131l\u0131\u011f\u0131yla<\/td><\/tr><tr><td>\u0130cra Riski<\/td><td>\u00dc\u00e7 segment aras\u0131nda entegrasyon karma\u015f\u0131kl\u0131\u011f\u0131<\/td><td>Ortakl\u0131k sonu\u00e7lar\u0131 \u00fczerinde s\u0131n\u0131rl\u0131 kontrol<\/td><\/tr><tr><td>Rekabet Yo\u011funlu\u011fu<\/td><td>Dikey entegrasyon engelleri ile korunuyor<\/td><td>Saf perakende ve dijital rekabete maruz<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS, ba\u015flang\u0131\u00e7ta \u00f6ng\u00f6r\u00fclenin %12 \u00fczerinde IT entegrasyon maliyetleri ile kan\u0131tlanan entegrasyon icra zorluklar\u0131yla kar\u015f\u0131 kar\u015f\u0131ya, ancak beklenenden daha g\u00fc\u00e7l\u00fc gelir sinerjileri ile dengeleniyor. 70+ milyon eczane m\u00fc\u015fterisi, 105+ milyon PBM hayat\u0131 ve 25+ milyon sigorta \u00fcyesini koordine etmenin karma\u015f\u0131kl\u0131\u011f\u0131 operasyonel s\u00fcrt\u00fcnme yarat\u0131r ancak potansiyel rekabet avantajlar\u0131 sunar.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Walgreens, CVS'nin %15 maruziyetine k\u0131yasla dijital bozulmaya %22 re\u00e7ete hacmi ile daha do\u011frudan rekabet tehditleriyle kar\u015f\u0131 kar\u015f\u0131ya. \u015eirketin %35 \u00f6n ma\u011faza perakende sat\u0131\u015f ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, Amazon ve do\u011frudan t\u00fcketiciye rekabet savunmas\u0131zl\u0131\u011f\u0131n\u0131 art\u0131r\u0131rken, ortakl\u0131k ba\u011f\u0131ml\u0131 sa\u011fl\u0131k stratejisi, VillageMD uygulama hedefleri ka\u00e7\u0131r\u0131ld\u0131\u011f\u0131nda \u00f6nemli icra riski getirir.<\/p><\/div><div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Portf\u00f6y Tahsis Stratejileri: CVS ve Walgreens Hisse Senedi<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Etkili portf\u00f6y olu\u015fturma, yat\u0131r\u0131m hedefleri, zaman ufku ve risk tolerans\u0131na dayal\u0131 olarak bu eczane perakende hisse senetleri aras\u0131nda stratejik konumland\u0131rma gerektirir.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Gelir odakl\u0131 yat\u0131r\u0131mc\u0131lar, genellikle Walgreens'e portf\u00f6ylerinin %2-3'\u00fcn\u00fc ay\u0131r\u0131r, \u00e7\u00fcnk\u00fc mevcut %4.8 temett\u00fc verimi sunar, ancak temett\u00fc kar\u015f\u0131lama oran\u0131 son \u00fc\u00e7 y\u0131lda %2.4'ten %1.8'e d\u00fc\u015ferek s\u00fcrd\u00fcr\u00fclebilirlik endi\u015felerini art\u0131r\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>B\u00fcy\u00fcme odakl\u0131 yat\u0131r\u0131mc\u0131lar, genellikle CVS'nin sa\u011fl\u0131k ekosistem modelini tercih eder, savunmac\u0131 sa\u011fl\u0131k \u00f6zelliklerini ve de\u011fer bazl\u0131 bak\u0131m ge\u00e7i\u015flerinden b\u00fcy\u00fcmeyi yakalamak i\u00e7in %1.5-2.5 portf\u00f6y maruziyeti ay\u0131r\u0131r.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option yat\u0131r\u0131m stratejistleri, etkili eczane perakende tahsis yakla\u015f\u0131mlar\u0131n\u0131 belirlemi\u015ftir:<\/p><\/div><div class='po-container po-container_width_article-sm article-content po-article-page__text'><ul class='po-article-page-list'><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Dengeli sa\u011fl\u0131k maruziyeti: %60 CVS \/ %40 Walgreens a\u011f\u0131rl\u0131\u011f\u0131, CVS'nin entegre model istikrar\u0131n\u0131 yakalarken Walgreens'in potansiyel d\u00f6n\u00fc\u015f\u00fcm yukar\u0131 potansiyelini korur.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\u00c7ift ticaret: \u0130statistiksel arbitraj stratejileri, fiyat sapmas\u0131 1.5 standart sapmay\u0131 a\u015ft\u0131\u011f\u0131nda hisse senetlerinin 0.68 korelasyon katsay\u0131s\u0131ndan yararlanabilir.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Ekonomik duyarl\u0131l\u0131k konumland\u0131rmas\u0131: Durgunluk d\u00f6nemlerinde CVS tahsisini art\u0131rmak, Walgreens'in 0.90 beta katsay\u0131s\u0131na kar\u015f\u0131 0.75 beta katsay\u0131s\u0131n\u0131 kullanarak geli\u015fmi\u015f a\u015fa\u011f\u0131 y\u00f6nl\u00fc koruma sa\u011flar.<\/li><li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Opsiyon stratejileri: Walgreens hisse senedi \u00fczerinde kapal\u0131 \u00e7a\u011fr\u0131 yakla\u015f\u0131mlar\u0131, prim geliri yoluyla y\u0131ll\u0131k %3-5 ekleyerek %4.8 temett\u00fc verimini art\u0131r\u0131r.<\/li><\/ul><\/div>[cta_button text=\"\"]<div class='po-container po-container_width_article-sm'><h2 class='po-article-page__title'>Gelecek G\u00f6r\u00fcn\u00fcm\u00fc ve Sonu\u00e7<\/h2><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Eczane perakende manzaras\u0131, sa\u011fl\u0131k hizmeti sunum d\u00f6n\u00fc\u015f\u00fcm\u00fc, dijital h\u0131zlanma ve de\u011fi\u015fen t\u00fcketici beklentileri ile evrim ge\u00e7irmeye devam ediyor. Birka\u00e7 kritik trend, do\u011frudan CVS ve Walgreens hisse senedi potansiyelini etkiler.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>De\u011fer bazl\u0131 bak\u0131m modelleri art\u0131k sa\u011fl\u0131k geri \u00f6demesinin %15'ini etkiliyor ve 2026'ya kadar %25'e ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor. CVS'nin entegre yakla\u015f\u0131m\u0131, eczane, PBM ve sigorta segmentleri aras\u0131nda kapsaml\u0131 hasta verileri ile avantajl\u0131 bir konuma getiriyor. Walgreens'in ortakl\u0131k stratejisi, icra ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 yarat\u0131r ancak de\u011fer bazl\u0131 bak\u0131m kat\u0131l\u0131m\u0131 i\u00e7in potansiyel olarak daha d\u00fc\u015f\u00fck sermaye gereksinimleri sunar.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Dijital sa\u011fl\u0131k benimsemesi, 2019'dan bu yana sa\u011fl\u0131k etkile\u015fimlerinin %11'inden %38'ine h\u0131zland\u0131. CVS, re\u00e7etelerin %45'ini dijital kanallar arac\u0131l\u0131\u011f\u0131yla i\u015flerken, Walgreens %38'ini i\u015fliyor, bu da dijital d\u00f6n\u00fc\u015f\u00fcm etkinli\u011findeki farkl\u0131l\u0131klar\u0131 yans\u0131t\u0131yor.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>CVS ve Walgreens hisse senedi kar\u015f\u0131la\u015ft\u0131rmas\u0131, iki farkl\u0131 sa\u011fl\u0131k d\u00f6n\u00fc\u015f\u00fcm yakla\u015f\u0131m\u0131n\u0131 ortaya koyuyor. CVS, 69 milyar dolarl\u0131k Aetna sat\u0131n al\u0131m\u0131yla dikey entegrasyonu takip etti, sa\u011fl\u0131k ekosistemi geli\u015ftirmek i\u00e7in daha y\u00fcksek bor\u00e7 ve entegrasyon karma\u015f\u0131kl\u0131\u011f\u0131n\u0131 kabul etti. Walgreens, daha d\u00fc\u015f\u00fck sermaye gereksinimleri ancak artan ba\u011f\u0131ml\u0131l\u0131k riskleri ile 5.2 milyar dolarl\u0131k ortakl\u0131k odakl\u0131 bir model uygulad\u0131.<\/p><\/div><div class='po-container po-container_width_article-sm'><p class='po-article-page__text'>Pocket Option'\u0131n analitik \u00e7er\u00e7evesini kullanan yat\u0131r\u0131mc\u0131lar i\u00e7in, bu hisse senetleri aras\u0131ndaki tahsis kararlar\u0131 belirli yat\u0131r\u0131m hipotezleriyle uyumlu olmal\u0131d\u0131r: CVS, %0.75 beta katsay\u0131s\u0131 ve 8.7x ileri F\/K oran\u0131 ile daha g\u00fc\u00e7l\u00fc savunmac\u0131 \u00f6zellikler sunarken, Walgreens, 6.9x ileri F\/K ile potansiyel de\u011fer sunar ancak ortakl\u0131k stratejisinde artan icra riski ta\u015f\u0131r.<\/p><\/div>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Rekabet\u00e7i Manzara: Perakende Eczac\u0131l\u0131kta CVS ve Walgreens Hisse Senetleri<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Eczane perakende yat\u0131r\u0131mlar\u0131, portf\u00f6y \u00e7e\u015fitlendirmesi i\u00e7in benzersiz sa\u011fl\u0131k hizmeti maruziyeti sunar. CVS ve Walgreens hisse senetlerini incelerken, yat\u0131r\u0131mc\u0131lar bu \u015firketlerin farkl\u0131 i\u015f modelleri, b\u00fcy\u00fcme yollar\u0131 ve pazar pozisyonlar\u0131 ile kapsaml\u0131 sa\u011fl\u0131k ekosistemlerini temsil etti\u011fini fark etmelidir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS, sigorta ve eczane fayda y\u00f6netimi yoluyla dikey entegrasyonu takip ederken, Walgreens uluslararas\u0131 geni\u015fleme ve stratejik ortakl\u0131klara vurgu yap\u0131yor\u2014temelde farkl\u0131 yat\u0131r\u0131m profilleri olu\u015fturuyor. Pocket Option analistleri, hedefe y\u00f6nelik yat\u0131r\u0131m i\u00e7g\u00f6r\u00fcleri sa\u011flamak i\u00e7in bu farkl\u0131l\u0131klar\u0131 izler.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Tarihsel Performans Analizi: Walgreens Hisse Senedi ve CVS Hisse Senedi<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens hisse senedi ve CVS hisse senedini do\u011fru bir \u015fekilde de\u011ferlendirmek i\u00e7in tarihsel performans verileri, her \u015firketin stratejik kararlar\u0131n\u0131 ve pazar uyumunu yans\u0131tan belirli fiyat trendlerini ortaya koyar.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Performans Metrikleri<\/th>\n<th>CVS Health (CVS)<\/th>\n<th>Walgreens Boots Alliance (WBA)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 Y\u0131ll\u0131k Hisse Senedi Performans\u0131<\/td>\n<td>%12 art\u0131\u015f, %22 volatilite<\/td>\n<td>%45 d\u00fc\u015f\u00fc\u015f, %30 volatilite<\/td>\n<\/tr>\n<tr>\n<td>Temett\u00fc Verimi (G\u00fcncel)<\/td>\n<td>%3.2<\/td>\n<td>%4.8<\/td>\n<\/tr>\n<tr>\n<td>F\/K Oran\u0131 (G\u00fcncel)<\/td>\n<td>8.7x<\/td>\n<td>6.9x<\/td>\n<\/tr>\n<tr>\n<td>Gelir B\u00fcy\u00fcmesi (5 Y\u0131ll\u0131k Bile\u015fik Y\u0131ll\u0131k B\u00fcy\u00fcme Oran\u0131)<\/td>\n<td>%8.9<\/td>\n<td>%3.2<\/td>\n<\/tr>\n<tr>\n<td>EBITDA Marj\u0131 (G\u00fcncel)<\/td>\n<td>%6.8<\/td>\n<td>%4.5<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS&#8217;nin 2018&#8217;de sa\u011fl\u0131k sigortac\u0131s\u0131 Aetna&#8217;y\u0131 69 milyar dolara sat\u0131n almas\u0131, bor\u00e7-EBITDA oran\u0131n\u0131 4.6x&#8217;e \u00e7\u0131kard\u0131 ancak y\u0131ll\u0131k 900+ milyon dolarl\u0131k sinerji sa\u011flayarak 3.0x&#8217;e d\u00fc\u015f\u00fcrd\u00fc ve hisse senedi performans\u0131n\u0131 istikrara kavu\u015fturdu. Buna kar\u015f\u0131l\u0131k, Walgreens yatay geni\u015flemeye odaklanarak WBA hisse de\u011fer art\u0131\u015f\u0131 i\u00e7in kar\u0131\u015f\u0131k sonu\u00e7lar elde etti.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>Pazar D\u00f6ng\u00fcleri ve Eczane Hisse Senedi Performans\u0131<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS ve Walgreens hisse senedi fiyatlar\u0131 ekonomik d\u00f6ng\u00fcler s\u0131ras\u0131nda \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131l\u0131k g\u00f6sterir, be\u015f y\u0131ll\u0131k beta katsay\u0131lar\u0131 s\u0131ras\u0131yla 0.75 ve 0.90 olup, pazar hareketlerine farkl\u0131 duyarl\u0131l\u0131k g\u00f6sterir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>2020 pazar d\u00fc\u015f\u00fc\u015f\u00fc s\u0131ras\u0131nda, CVS hisse senedi %14 d\u00fc\u015ferken Walgreens %28 d\u00fc\u015ft\u00fc, bu da CVS&#8217;nin eczane fayda y\u00f6netimi ve sigorta segmentlerindeki \u00e7e\u015fitlendirilmi\u015f gelir ak\u0131\u015flar\u0131ndan \u00fcst\u00fcn dayan\u0131kl\u0131l\u0131\u011f\u0131n\u0131 g\u00f6sterdi.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>\u0130\u015f Modeli Kar\u015f\u0131la\u015ft\u0131rmas\u0131: WBA ve CVS Hisse Senedi Temelleri<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Bu \u015firketlerin operasyonel stratejileri, gelir istikrar\u0131, marj profilleri ve b\u00fcy\u00fcme potansiyelini do\u011frudan etkiler\u2014WBA ve CVS hisse senedi yat\u0131r\u0131m de\u011ferini de\u011ferlendirirken anahtar fakt\u00f6rlerdir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>\u0130\u015f Segmenti<\/th>\n<th>CVS Health Yakla\u015f\u0131m\u0131<\/th>\n<th>Walgreens Boots Alliance Yakla\u015f\u0131m\u0131<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Perakende Eczane<\/td>\n<td>9,900 lokasyon, 1,100 MinuteClinic sitesi<\/td>\n<td>9,000 ABD lokasyonu, 13,000+ k\u00fcresel<\/td>\n<\/tr>\n<tr>\n<td>Sa\u011fl\u0131k Hizmetleri<\/td>\n<td>Caremark PBM (105M+ hayat), Aetna (25M+ \u00fcye)<\/td>\n<td>VillageMD hissesi (%55), CareCentrix sat\u0131n al\u0131m\u0131<\/td>\n<\/tr>\n<tr>\n<td>Dijital Strateji<\/td>\n<td>43M+ kullan\u0131c\u0131ya sahip entegre uygulama, ba\u011fl\u0131 kay\u0131tlar<\/td>\n<td>myWalgreens platformu (92M \u00fcye), teslimat ortakl\u0131klar\u0131<\/td>\n<\/tr>\n<tr>\n<td>Uluslararas\u0131 Varl\u0131k<\/td>\n<td>Gelirin &lt;%2&#8217;si uluslararas\u0131 operasyonlardan<\/td>\n<td>Gelirin ~%25&#8217;i uluslararas\u0131 pazarlardan<\/td>\n<\/tr>\n<tr>\n<td>Bor\u00e7 Yap\u0131s\u0131<\/td>\n<td>67.4 milyar dolar uzun vadeli bor\u00e7, 3.0x bor\u00e7-EBITDA oran\u0131<\/td>\n<td>38.5 milyar dolar uzun vadeli bor\u00e7, 2.6x bor\u00e7-EBITDA oran\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS, 9,900 eczane lokasyonu, y\u0131ll\u0131k 2+ milyar re\u00e7ete i\u015fleyen Caremark PBM hizmetleri ve Aetna&#8217;n\u0131n 25+ milyon sigorta \u00fcyesini birle\u015ftirerek entegre bir sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131s\u0131 olarak faaliyet g\u00f6sterir. Bu entegrasyon 80+ milyar dolarl\u0131k sermaye gerektirdi ancak savunmac\u0131 gelir \u00f6zellikleri ve %15 \u00e7apraz sat\u0131\u015f b\u00fcy\u00fcme f\u0131rsatlar\u0131 yaratt\u0131.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens, tam sat\u0131n al\u0131mlar yerine VillageMD&#8217;ye 5.2 milyar dolar ve CareCentrix&#8217;e 330 milyon dolar yat\u0131r\u0131m yapt\u0131. Bu sermaye hafif strateji, bilan\u00e7o esnekli\u011fini korur ancak ortaklar\u0131n icras\u0131na ba\u011f\u0131ml\u0131l\u0131k yarat\u0131r, bu da nihayetinde WBA hisse performans\u0131n\u0131 etkiler.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>Marj Yap\u0131s\u0131 ve Karl\u0131l\u0131k Kar\u015f\u0131la\u015ft\u0131rmas\u0131<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option analistleri, rakipler aras\u0131nda belirgin marj profilleri belirler: CVS, PBM entegrasyon verimlilikleri sayesinde %5.3 i\u015fletme marjlar\u0131n\u0131 korurken, Walgreens&#8217;in %3.8 marjlar\u0131, \u00f6n ma\u011faza perakende ekonomilerine daha fazla maruz kalmay\u0131 yans\u0131t\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Karl\u0131l\u0131k Metrikleri<\/th>\n<th>CVS Health<\/th>\n<th>Walgreens Boots Alliance<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Br\u00fct Marj<\/td>\n<td>%18.9<\/td>\n<td>%21.5<\/td>\n<\/tr>\n<tr>\n<td>\u0130\u015fletme Marj\u0131<\/td>\n<td>%5.3<\/td>\n<td>%3.8<\/td>\n<\/tr>\n<tr>\n<td>Net Kar Marj\u0131<\/td>\n<td>%3.1<\/td>\n<td>%2.2<\/td>\n<\/tr>\n<tr>\n<td>Varl\u0131k Getirisi<\/td>\n<td>%4.2<\/td>\n<td>%2.5<\/td>\n<\/tr>\n<tr>\n<td>\u00d6zsermaye Getirisi<\/td>\n<td>%12.8<\/td>\n<td>%9.6<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>CVS ve Walgreens Hisse Senedi G\u00f6r\u00fcn\u00fcm\u00fcn\u00fc Etkileyen Stratejik Giri\u015fimler<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Her iki \u015firket de i\u015f modellerini sa\u011fl\u0131k hizmeti bozulmas\u0131, dijital h\u0131zlanma ve de\u011fi\u015fen t\u00fcketici tercihlerini ele almak i\u00e7in d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor\u2014bu geli\u015fmeler do\u011frudan CVS ve Walgreens hisse senedi y\u00f6r\u00fcngelerini etkiliyor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS, 900+ HealthHUB lokasyonunu geni\u015fletmek i\u00e7in 1.5 milyar dolar yat\u0131r\u0131m yapt\u0131, ma\u011fazalar\u0131 diyabet bak\u0131m\u0131, uyku apnesi de\u011ferlendirmesi ve flebotomi hizmetleri dahil olmak \u00fczere geni\u015fletilmi\u015f klinik hizmetler sunan sa\u011fl\u0131k destinasyonlar\u0131na d\u00f6n\u00fc\u015ft\u00fcrd\u00fc. Bu yenileme, %15 daha y\u00fcksek re\u00e7ete yakalama oranlar\u0131 ve %8 artan ma\u011faza trafi\u011fi sa\u011fl\u0131yor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens, 2025 y\u0131l\u0131na kadar Walgreens ma\u011fazalar\u0131 ile birlikte 1,000 tam hizmet birinci basamak sa\u011fl\u0131k uygulamas\u0131 kurarak VillageMD&#8217;ye 5.2 milyar dolar taahh\u00fct etti. Bu ortakl\u0131k temelli yakla\u015f\u0131m, ba\u015flang\u0131\u00e7 sermaye gereksinimlerini azaltt\u0131 ancak uygulama hedeflerinin ka\u00e7\u0131r\u0131lmas\u0131n\u0131n ard\u0131ndan WBA hisse senedi oynakl\u0131\u011f\u0131n\u0131 art\u0131ran icra ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 getirdi.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>CVS, 2+ milyon hayat\u0131 kapsayan risk bazl\u0131 s\u00f6zle\u015fmeleri g\u00fcvence alt\u0131na almak i\u00e7in entegre modelini kullanarak, %15 y\u0131ll\u0131k b\u00fcy\u00fcme projeksiyonlar\u0131 ile 250+ milyon dolar de\u011fer bazl\u0131 bak\u0131m geliri \u00fcretiyor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Walgreens, 9 \u00fclkede operasyonlar\u0131n\u0131 s\u00fcrd\u00fcrerek co\u011frafi \u00e7e\u015fitlilik yarat\u0131yor ancak 2023&#8217;te kazan\u00e7 oynakl\u0131\u011f\u0131n\u0131 %3.5 art\u0131ran d\u00f6viz \u00e7evirim etkileri getiriyor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Her iki \u015firket de geleneksel eczane hizmetlerinin \u00f6tesine ge\u00e7erek klinik hizmetlerini geni\u015fletiyor, CVS MinuteClinic ziyaretlerinde %22 y\u0131ll\u0131k b\u00fcy\u00fcme sa\u011flarken Walgreens VillageMD kar\u015f\u0131la\u015fmalar\u0131nda %17 b\u00fcy\u00fcme elde ediyor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Re\u00e7ete otomasyonu ve merkezi yerine getirme konusundaki teknoloji yat\u0131r\u0131mlar\u0131, CVS i\u00e7in i\u015f\u00e7ilik maliyetlerini %8-10, Walgreens i\u00e7in %6-8 oran\u0131nda azaltarak do\u011frudan marj profillerini iyile\u015ftiriyor.<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Finansal Sa\u011fl\u0131k: CVS ve WBA Hisse Senedi Temelleri<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Bilan\u00e7o g\u00fcc\u00fc, nakit ak\u0131\u015f\u0131 \u00fcretimi ve sermaye tahsis \u00f6ncelikleri, CVS ve WBA hisse senedi risk profillerini ve uzun vadeli de\u011fer art\u0131\u015f potansiyelini \u00f6nemli \u00f6l\u00e7\u00fcde etkiler.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Finansal Metrik<\/th>\n<th>CVS Health<\/th>\n<th>Walgreens Boots Alliance<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Bor\u00e7-EBITDA Oran\u0131<\/td>\n<td>3.0x (2018&#8217;de 4.6x&#8217;den d\u00fc\u015ft\u00fc)<\/td>\n<td>2.6x (2020&#8217;de 1.9x&#8217;den artt\u0131)<\/td>\n<\/tr>\n<tr>\n<td>Serbest Nakit Ak\u0131\u015f\u0131<\/td>\n<td>Y\u0131ll\u0131k 12.5 milyar dolar<\/td>\n<td>Y\u0131ll\u0131k 3.8 milyar dolar<\/td>\n<\/tr>\n<tr>\n<td>Temett\u00fc Da\u011f\u0131t\u0131m Oran\u0131<\/td>\n<td>%32<\/td>\n<td>%42<\/td>\n<\/tr>\n<tr>\n<td>Sermaye Harcamas\u0131<\/td>\n<td>2.8 milyar dolar (%1.8 gelir)<\/td>\n<td>1.7 milyar dolar (%2.1 gelir)<\/td>\n<\/tr>\n<tr>\n<td>Faiz Kar\u015f\u0131lama Oran\u0131<\/td>\n<td>8.2x<\/td>\n<td>6.1x<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS&#8217;nin 67.4 milyar dolarl\u0131k uzun vadeli borcu, Aetna sat\u0131n al\u0131m\u0131ndan bu yana %12 azald\u0131 ve y\u0131ll\u0131k 12.5 milyar dolar serbest nakit ak\u0131\u015f\u0131 \u00fcreterek hem bor\u00e7 hizmeti hem de %3.2 temett\u00fc verimi yoluyla hissedar getirilerini destekliyor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens, sa\u011fl\u0131k yat\u0131r\u0131mlar\u0131n\u0131 finanse etmek i\u00e7in kald\u0131ra\u00e7 oran\u0131n\u0131 1.9x&#8217;den 2.6x bor\u00e7-EBITDA&#8217;ya \u00e7\u0131kard\u0131 ve temett\u00fc aristokrat stat\u00fcs\u00fcn\u00fc korudu. Bu sermaye tahsis stratejisi, WBA&#8217;n\u0131n temett\u00fc kar\u015f\u0131lama oran\u0131n\u0131n \u00fc\u00e7 y\u0131l i\u00e7inde 2.4x&#8217;den 1.8x&#8217;e d\u00fc\u015fmesiyle ilgili endi\u015feleri art\u0131r\u0131yor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>Sermaye Tahsis \u00d6ncelikleri ve Hissedar Getirileri<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Farkl\u0131 sermaye tahsis yakla\u015f\u0131mlar\u0131, farkl\u0131 hissedar getiri profilleri yarat\u0131r. CVS, Aetna sat\u0131n al\u0131m\u0131n\u0131n ard\u0131ndan \u00fc\u00e7 y\u0131l boyunca temett\u00fc art\u0131\u015flar\u0131n\u0131 ge\u00e7ici olarak ask\u0131ya ald\u0131 ancak 2022&#8217;de %10 y\u0131ll\u0131k temett\u00fc b\u00fcy\u00fcmesine devam etti ve 10 milyar dolarl\u0131k hisse geri al\u0131m program\u0131 ba\u015flatt\u0131.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens, \u015fu anda %4.8 getiri sa\u011flayan 47 y\u0131l boyunca temett\u00fc art\u0131\u015flar\u0131n\u0131 s\u00fcrd\u00fcrd\u00fc. Ancak, bu taahh\u00fct stratejik esnekli\u011fi k\u0131s\u0131tl\u0131yor, \u015firketin tarihi de\u011ferleme d\u00fc\u015f\u00fck seviyelerinde i\u015flem g\u00f6rmesine ra\u011fmen s\u0131n\u0131rl\u0131 1 milyar dolarl\u0131k hisse geri al\u0131m program\u0131 ile kan\u0131tland\u0131\u011f\u0131 gibi.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>CVS, sa\u011fl\u0131k hizmeti geni\u015flemesinde stratejik yat\u0131r\u0131mlara y\u0131ll\u0131k 2.8 milyar dolar tahsis ediyor, HealthHUB yenilemeleri lokasyon ba\u015f\u0131na 450,000 dolara mal oluyor ancak %18 ROI sa\u011fl\u0131yor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Walgreens, 5.2 milyar dolarl\u0131k VillageMD yat\u0131r\u0131m\u0131n\u0131n %65&#8217;ini ABD operasyonlar\u0131na y\u00f6nlendirdi, geri kalan\u0131 ise \u0130ngiltere ve Almanya&#8217;daki uluslararas\u0131 klinik modellerini destekliyor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Her iki \u015firket de otomasyona yat\u0131r\u0131m yap\u0131yor, CVS&#8217;nin 600 milyon dolarl\u0131k merkezi yerine getirme merkezleri re\u00e7ete hacminin %50&#8217;sini i\u015fleyerek da\u011f\u0131t\u0131m maliyetlerini %15 azalt\u0131yor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Hisse geri al\u0131m faaliyeti \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131l\u0131k g\u00f6steriyor: CVS, 2022&#8217;den bu yana 3.5 milyar dolarl\u0131k hisse geri ald\u0131, Walgreens ise daha b\u00fcy\u00fck de\u011ferleme indirimlerine ra\u011fmen sadece 500 milyon dolarl\u0131k geri al\u0131m yapt\u0131.<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>D\u00fczenleyici Ortam\u0131n Walgreens ve CVS Hisse Senedi Performans\u0131na Etkisi<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>D\u00fczenleyici geli\u015fmeler, eczane operasyonlar\u0131n\u0131, sa\u011fl\u0131k hizmeti sunum modellerini ve nihayetinde Walgreens ve CVS hisse senedi performans y\u00f6r\u00fcngelerini do\u011frudan etkiler.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>D\u00fczenleyici Fakt\u00f6r<\/th>\n<th>CVS Health Etkisi<\/th>\n<th>Walgreens Boots Alliance Etkisi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u0130la\u00e7 Fiyatland\u0131rma Reformlar\u0131<\/td>\n<td>%1.8 EBITDA etkisi, %2.2 Aetna faydas\u0131 ile dengeleniyor<\/td>\n<td>%2.5 EBITDA etkisi, s\u0131n\u0131rl\u0131 dengeleyici fakt\u00f6rler<\/td>\n<\/tr>\n<tr>\n<td>Sa\u011fl\u0131k Sigortas\u0131 Geni\u015flemesi<\/td>\n<td>%3.5 gelir f\u0131rsat\u0131 Aetna kayd\u0131 ile<\/td>\n<td>%1.7 re\u00e7ete hacmi art\u0131\u015f potansiyeli<\/td>\n<\/tr>\n<tr>\n<td>Eczane Geri \u00d6demesi<\/td>\n<td>%1.5 marj etkisi, k\u0131smen PBM operasyonlar\u0131 taraf\u0131ndan absorbe ediliyor<\/td>\n<td>%2.1 marj etkisi, do\u011frudan P&amp;L maruziyeti<\/td>\n<\/tr>\n<tr>\n<td>Uluslararas\u0131 D\u00fczenlemeler<\/td>\n<td>&lt;%0.5 etki, s\u0131n\u0131rl\u0131 uluslararas\u0131 maruziyet<\/td>\n<td>%1.2 etki, \u0130ngiltere NHS geri \u00f6deme de\u011fi\u015fikliklerinden<\/td>\n<\/tr>\n<tr>\n<td>Antitr\u00f6st \u0130nceleme<\/td>\n<td>Dikey entegrasyon i\u00e7in potansiyel elden \u00e7\u0131karma gereklilikleri<\/td>\n<td>S\u0131n\u0131rl\u0131 dikey konsolidasyon nedeniyle daha d\u00fc\u015f\u00fck risk profili<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>2022 Enflasyon Azaltma Yasas\u0131&#8217;n\u0131n Medicare ila\u00e7 fiyat\u0131 m\u00fczakere h\u00fck\u00fcmleri, her iki \u015firketi farkl\u0131 \u015fekilde etkiler: CVS, Aetna Medicare planlar\u0131 arac\u0131l\u0131\u011f\u0131yla fayda sa\u011flayabilirken, PBM \u015feffafl\u0131k gereklilikleriyle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131rken, Walgreens %1.5-2.0 eczane marj s\u0131k\u0131\u015fmas\u0131 tahminleriyle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131yor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens&#8217;in uluslararas\u0131 operasyonlar\u0131, \u0130ngiltere pazar\u0131nda Boots eczane marjlar\u0131n\u0131 2023&#8217;te 120 baz puan azaltan NHS geri \u00f6deme bask\u0131lar\u0131 dahil olmak \u00fczere \u00e7e\u015fitli d\u00fczenleyici \u00e7er\u00e7evelere maruz kal\u0131yor. CVS&#8217;nin yerel odaklanmas\u0131, uluslararas\u0131 d\u00fczenleyici maruziyeti s\u0131n\u0131rlar ancak ABD sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fikliklerinde riski yo\u011funla\u015ft\u0131r\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Yat\u0131r\u0131m Tezi: CVS ve Walgreens Hisse Senedi \u00dczerine Analist Perspektifi<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Profesyonel yat\u0131r\u0131mc\u0131lar, her \u015firket i\u00e7in stratejik icra, konumland\u0131rma ve sa\u011fl\u0131k sekt\u00f6r\u00fc trendlerine dayal\u0131 olarak farkl\u0131 yat\u0131r\u0131m tezleri geli\u015ftirir. Pocket Option piyasa analistleri, her hissenin yat\u0131r\u0131m de\u011ferini \u015fekillendiren anahtar fakt\u00f6rleri belirlemi\u015ftir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>CVS Health \u0130\u00e7in Bo\u011fa Durumu<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS bo\u011falar\u0131, Aetna entegrasyonundan elde edilen y\u0131ll\u0131k 900+ milyon dolarl\u0131k sinerji yakalama ba\u015far\u0131s\u0131n\u0131, ba\u015flang\u0131\u00e7 hedeflerini %20 a\u015farak 2024&#8217;e kadar 500+ milyon dolarl\u0131k ek gelir \u00fcretecek HealthHUB lokasyonlar\u0131n\u0131 geni\u015fletmeyi vurgular.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>MinuteClinic ve HealthHUB lokasyonlar\u0131, %12 daha y\u00fcksek re\u00e7ete yakalama oranlar\u0131 sa\u011flarken, \u00f6n ma\u011faza al\u0131\u015fveri\u015flerini %8 art\u0131rarak de\u011ferli \u00e7apraz sat\u0131\u015f f\u0131rsatlar\u0131 yarat\u0131yor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Dijital sa\u011fl\u0131k giri\u015fimleri, 43+ milyon uygulama kullan\u0131c\u0131s\u0131n\u0131 y\u00fcz y\u00fcze deneyimlerle ba\u011flayarak, %22 daha y\u00fcksek ila\u00e7 uyumu ve %15 artan re\u00e7ete yenilemeleri sa\u011fl\u0131yor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Bor\u00e7 azalt\u0131m\u0131, finansal esnekli\u011fi g\u00fc\u00e7lendirdi, y\u0131ll\u0131k 12.5 milyar dolar serbest nakit ak\u0131\u015f\u0131, hem %3.2 temett\u00fc verimini hem de 10 milyar dolarl\u0131k hisse geri al\u0131m yetkisini destekliyor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>De\u011fer bazl\u0131 bak\u0131m giri\u015fimleri, art\u0131k 2+ milyon hayat\u0131 kaps\u0131yor, CVS&#8217;yi sa\u011fl\u0131k geri \u00f6demesinin hizmet ba\u015f\u0131na \u00fccret modelinden sonu\u00e7 bazl\u0131 modellere ge\u00e7i\u015fiyle avantajl\u0131 bir konuma getiriyor.<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h3 class='po-article-page__title'>Walgreens Boots Alliance \u0130\u00e7in Bo\u011fa Durumu<\/h3>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens bo\u011falar\u0131, \u015firketin 5 milyar dolarl\u0131k maliyet d\u00f6n\u00fc\u015f\u00fcm giri\u015fimlerini ve VillageMD arac\u0131l\u0131\u011f\u0131yla stratejik yeniden konumland\u0131rmas\u0131n\u0131 vurguluyor, hisse senedinin sekt\u00f6r\u00fcn 12.8x ortalamas\u0131na kar\u015f\u0131 6.9x ileri F\/K oran\u0131nda \u00f6nemli bir d\u00fc\u015f\u00fck de\u011ferleme g\u00f6sterdi\u011fine i\u015faret ediyor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>VillageMD ortakl\u0131\u011f\u0131, 2025 y\u0131l\u0131na kadar 1,000 birinci basamak sa\u011fl\u0131k lokasyonunu geni\u015fleterek, birlikte konumland\u0131r\u0131lm\u0131\u015f Walgreens eczanelerinde %30-35 ek re\u00e7ete b\u00fcy\u00fcmesi sa\u011fl\u0131yor.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Uluslararas\u0131 operasyonlar co\u011frafi \u00e7e\u015fitlilik sa\u011flar, \u0130ngiltere ve Alman pazarlar\u0131 ABD operasyonlar\u0131na g\u00f6re %1.2 daha y\u00fcksek eczane marjlar\u0131 sunar.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>2024&#8217;e kadar 3.5 milyar dolar tasarruf hedefleyen maliyet d\u00f6n\u00fc\u015f\u00fcm program\u0131, geri \u00f6deme bask\u0131lar\u0131na ra\u011fmen EBITDA marjlar\u0131n\u0131 80 baz puan art\u0131rarak zaten 2.2 milyar dolar sa\u011flad\u0131.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Mevcut de\u011ferleme, 0.25x fiyat-sat\u0131\u015f oran\u0131nda, CVS&#8217;nin 0.50x \u00e7arpan\u0131na g\u00f6re %50 indirim sunuyor, icra iyile\u015firse \u00f6nemli bir yukar\u0131 potansiyel sunuyor.<\/li>\n<\/ul>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>De\u011ferleme Metrikleri<\/th>\n<th>CVS Health<\/th>\n<th>Walgreens Boots Alliance<\/th>\n<th>Sekt\u00f6r Ortalamas\u0131<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u0130leri F\/K Oran\u0131<\/td>\n<td>8.7x<\/td>\n<td>6.9x<\/td>\n<td>12.8x<\/td>\n<\/tr>\n<tr>\n<td>EV\/EBITDA \u00c7arpan\u0131<\/td>\n<td>8.2x<\/td>\n<td>6.1x<\/td>\n<td>11.5x<\/td>\n<\/tr>\n<tr>\n<td>Fiyat-Sat\u0131\u015f Oran\u0131<\/td>\n<td>0.35x<\/td>\n<td>0.25x<\/td>\n<td>0.60x<\/td>\n<\/tr>\n<tr>\n<td>Temett\u00fc Verimi<\/td>\n<td>%3.2<\/td>\n<td>%4.8<\/td>\n<td>%2.2<\/td>\n<\/tr>\n<tr>\n<td>PEG Oran\u0131<\/td>\n<td>1.15<\/td>\n<td>1.75<\/td>\n<td>1.45<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Risk De\u011ferlendirmesi: WBA ve CVS Hisse Senedi Yat\u0131r\u0131m D\u00fc\u015f\u00fcnceleri<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Kapsaml\u0131 risk analizi, i\u015f kar\u0131\u015f\u0131m\u0131, stratejik icra ve finansal konumland\u0131rmaya dayal\u0131 olarak WBA ve CVS hisse senetleri aras\u0131nda belirgin savunmas\u0131zl\u0131k profilleri ortaya koyar.<\/p>\n<\/div>\n<div class='po-container po-container_width_article po-article-page__table'>\n<div class='po-table'>\n<table>\n<thead>\n<tr>\n<th>Risk Kategorisi<\/th>\n<th>CVS Health Maruziyeti<\/th>\n<th>Walgreens Boots Alliance Maruziyeti<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Eczane Geri \u00d6demesi<\/td>\n<td>Gelirin %42&#8217;si do\u011frudan maruz<\/td>\n<td>Gelirin %68&#8217;i do\u011frudan maruz<\/td>\n<\/tr>\n<tr>\n<td>Dijital Bozulma<\/td>\n<td>Eczane hacminin %15&#8217;i potansiyel olarak savunmas\u0131z<\/td>\n<td>Eczane hacminin %22&#8217;si potansiyel olarak savunmas\u0131z<\/td>\n<\/tr>\n<tr>\n<td>Sa\u011fl\u0131k Politikas\u0131<\/td>\n<td>Kar\u0131\u015f\u0131k: Aetna kapsama de\u011fi\u015fikliklerine maruz<\/td>\n<td>S\u0131n\u0131rl\u0131: \u00d6ncelikle eczane kanallar\u0131 arac\u0131l\u0131\u011f\u0131yla<\/td>\n<\/tr>\n<tr>\n<td>\u0130cra Riski<\/td>\n<td>\u00dc\u00e7 segment aras\u0131nda entegrasyon karma\u015f\u0131kl\u0131\u011f\u0131<\/td>\n<td>Ortakl\u0131k sonu\u00e7lar\u0131 \u00fczerinde s\u0131n\u0131rl\u0131 kontrol<\/td>\n<\/tr>\n<tr>\n<td>Rekabet Yo\u011funlu\u011fu<\/td>\n<td>Dikey entegrasyon engelleri ile korunuyor<\/td>\n<td>Saf perakende ve dijital rekabete maruz<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS, ba\u015flang\u0131\u00e7ta \u00f6ng\u00f6r\u00fclenin %12 \u00fczerinde IT entegrasyon maliyetleri ile kan\u0131tlanan entegrasyon icra zorluklar\u0131yla kar\u015f\u0131 kar\u015f\u0131ya, ancak beklenenden daha g\u00fc\u00e7l\u00fc gelir sinerjileri ile dengeleniyor. 70+ milyon eczane m\u00fc\u015fterisi, 105+ milyon PBM hayat\u0131 ve 25+ milyon sigorta \u00fcyesini koordine etmenin karma\u015f\u0131kl\u0131\u011f\u0131 operasyonel s\u00fcrt\u00fcnme yarat\u0131r ancak potansiyel rekabet avantajlar\u0131 sunar.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Walgreens, CVS&#8217;nin %15 maruziyetine k\u0131yasla dijital bozulmaya %22 re\u00e7ete hacmi ile daha do\u011frudan rekabet tehditleriyle kar\u015f\u0131 kar\u015f\u0131ya. \u015eirketin %35 \u00f6n ma\u011faza perakende sat\u0131\u015f ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, Amazon ve do\u011frudan t\u00fcketiciye rekabet savunmas\u0131zl\u0131\u011f\u0131n\u0131 art\u0131r\u0131rken, ortakl\u0131k ba\u011f\u0131ml\u0131 sa\u011fl\u0131k stratejisi, VillageMD uygulama hedefleri ka\u00e7\u0131r\u0131ld\u0131\u011f\u0131nda \u00f6nemli icra riski getirir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Portf\u00f6y Tahsis Stratejileri: CVS ve Walgreens Hisse Senedi<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Etkili portf\u00f6y olu\u015fturma, yat\u0131r\u0131m hedefleri, zaman ufku ve risk tolerans\u0131na dayal\u0131 olarak bu eczane perakende hisse senetleri aras\u0131nda stratejik konumland\u0131rma gerektirir.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Gelir odakl\u0131 yat\u0131r\u0131mc\u0131lar, genellikle Walgreens&#8217;e portf\u00f6ylerinin %2-3&#8217;\u00fcn\u00fc ay\u0131r\u0131r, \u00e7\u00fcnk\u00fc mevcut %4.8 temett\u00fc verimi sunar, ancak temett\u00fc kar\u015f\u0131lama oran\u0131 son \u00fc\u00e7 y\u0131lda %2.4&#8217;ten %1.8&#8217;e d\u00fc\u015ferek s\u00fcrd\u00fcr\u00fclebilirlik endi\u015felerini art\u0131r\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>B\u00fcy\u00fcme odakl\u0131 yat\u0131r\u0131mc\u0131lar, genellikle CVS&#8217;nin sa\u011fl\u0131k ekosistem modelini tercih eder, savunmac\u0131 sa\u011fl\u0131k \u00f6zelliklerini ve de\u011fer bazl\u0131 bak\u0131m ge\u00e7i\u015flerinden b\u00fcy\u00fcmeyi yakalamak i\u00e7in %1.5-2.5 portf\u00f6y maruziyeti ay\u0131r\u0131r.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option yat\u0131r\u0131m stratejistleri, etkili eczane perakende tahsis yakla\u015f\u0131mlar\u0131n\u0131 belirlemi\u015ftir:<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm article-content po-article-page__text'>\n<ul class='po-article-page-list'>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Dengeli sa\u011fl\u0131k maruziyeti: %60 CVS \/ %40 Walgreens a\u011f\u0131rl\u0131\u011f\u0131, CVS&#8217;nin entegre model istikrar\u0131n\u0131 yakalarken Walgreens&#8217;in potansiyel d\u00f6n\u00fc\u015f\u00fcm yukar\u0131 potansiyelini korur.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>\u00c7ift ticaret: \u0130statistiksel arbitraj stratejileri, fiyat sapmas\u0131 1.5 standart sapmay\u0131 a\u015ft\u0131\u011f\u0131nda hisse senetlerinin 0.68 korelasyon katsay\u0131s\u0131ndan yararlanabilir.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Ekonomik duyarl\u0131l\u0131k konumland\u0131rmas\u0131: Durgunluk d\u00f6nemlerinde CVS tahsisini art\u0131rmak, Walgreens&#8217;in 0.90 beta katsay\u0131s\u0131na kar\u015f\u0131 0.75 beta katsay\u0131s\u0131n\u0131 kullanarak geli\u015fmi\u015f a\u015fa\u011f\u0131 y\u00f6nl\u00fc koruma sa\u011flar.<\/li>\n<li class='po-article-page__text po-article-page__text_no-margin po-list-lvl_1'>Opsiyon stratejileri: Walgreens hisse senedi \u00fczerinde kapal\u0131 \u00e7a\u011fr\u0131 yakla\u015f\u0131mlar\u0131, prim geliri yoluyla y\u0131ll\u0131k %3-5 ekleyerek %4.8 temett\u00fc verimini art\u0131r\u0131r.<\/li>\n<\/ul>\n<\/div>\n    <div class=\"po-container po-container_width_article\">\n        <a href=\"\/en\/quick-start\/\" class=\"po-line-banner po-article-page__line-banner\">\n            <svg class=\"svg-image po-line-banner__logo\" fill=\"currentColor\" width=\"auto\" height=\"auto\"\n                 aria-hidden=\"true\">\n                <use href=\"#svg-img-logo-white\"><\/use>\n            <\/svg>\n            <span class=\"po-line-banner__btn\"><\/span>\n        <\/a>\n    <\/div>\n    \n<div class='po-container po-container_width_article-sm'>\n<h2 class='po-article-page__title'>Gelecek G\u00f6r\u00fcn\u00fcm\u00fc ve Sonu\u00e7<\/h2>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Eczane perakende manzaras\u0131, sa\u011fl\u0131k hizmeti sunum d\u00f6n\u00fc\u015f\u00fcm\u00fc, dijital h\u0131zlanma ve de\u011fi\u015fen t\u00fcketici beklentileri ile evrim ge\u00e7irmeye devam ediyor. Birka\u00e7 kritik trend, do\u011frudan CVS ve Walgreens hisse senedi potansiyelini etkiler.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>De\u011fer bazl\u0131 bak\u0131m modelleri art\u0131k sa\u011fl\u0131k geri \u00f6demesinin %15&#8217;ini etkiliyor ve 2026&#8217;ya kadar %25&#8217;e ula\u015fmas\u0131 \u00f6ng\u00f6r\u00fcl\u00fcyor. CVS&#8217;nin entegre yakla\u015f\u0131m\u0131, eczane, PBM ve sigorta segmentleri aras\u0131nda kapsaml\u0131 hasta verileri ile avantajl\u0131 bir konuma getiriyor. Walgreens&#8217;in ortakl\u0131k stratejisi, icra ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 yarat\u0131r ancak de\u011fer bazl\u0131 bak\u0131m kat\u0131l\u0131m\u0131 i\u00e7in potansiyel olarak daha d\u00fc\u015f\u00fck sermaye gereksinimleri sunar.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Dijital sa\u011fl\u0131k benimsemesi, 2019&#8217;dan bu yana sa\u011fl\u0131k etkile\u015fimlerinin %11&#8217;inden %38&#8217;ine h\u0131zland\u0131. CVS, re\u00e7etelerin %45&#8217;ini dijital kanallar arac\u0131l\u0131\u011f\u0131yla i\u015flerken, Walgreens %38&#8217;ini i\u015fliyor, bu da dijital d\u00f6n\u00fc\u015f\u00fcm etkinli\u011findeki farkl\u0131l\u0131klar\u0131 yans\u0131t\u0131yor.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>CVS ve Walgreens hisse senedi kar\u015f\u0131la\u015ft\u0131rmas\u0131, iki farkl\u0131 sa\u011fl\u0131k d\u00f6n\u00fc\u015f\u00fcm yakla\u015f\u0131m\u0131n\u0131 ortaya koyuyor. CVS, 69 milyar dolarl\u0131k Aetna sat\u0131n al\u0131m\u0131yla dikey entegrasyonu takip etti, sa\u011fl\u0131k ekosistemi geli\u015ftirmek i\u00e7in daha y\u00fcksek bor\u00e7 ve entegrasyon karma\u015f\u0131kl\u0131\u011f\u0131n\u0131 kabul etti. Walgreens, daha d\u00fc\u015f\u00fck sermaye gereksinimleri ancak artan ba\u011f\u0131ml\u0131l\u0131k riskleri ile 5.2 milyar dolarl\u0131k ortakl\u0131k odakl\u0131 bir model uygulad\u0131.<\/p>\n<\/div>\n<div class='po-container po-container_width_article-sm'>\n<p class='po-article-page__text'>Pocket Option&#8217;\u0131n analitik \u00e7er\u00e7evesini kullanan yat\u0131r\u0131mc\u0131lar i\u00e7in, bu hisse senetleri aras\u0131ndaki tahsis kararlar\u0131 belirli yat\u0131r\u0131m hipotezleriyle uyumlu olmal\u0131d\u0131r: CVS, %0.75 beta katsay\u0131s\u0131 ve 8.7x ileri F\/K oran\u0131 ile daha g\u00fc\u00e7l\u00fc savunmac\u0131 \u00f6zellikler sunarken, Walgreens, 6.9x ileri F\/K ile potansiyel de\u011fer sunar ancak ortakl\u0131k stratejisinde artan icra riski ta\u015f\u0131r.<\/p>\n<\/div>\n"},"faq":[{"question":"CVS ve Walgreens i\u015f modelleri aras\u0131ndaki temel farklar nelerdir?","answer":"CVS, Aetna (sa\u011fl\u0131k sigortas\u0131) sat\u0131n alarak ve g\u00fc\u00e7l\u00fc bir PBM i\u015fini s\u00fcrd\u00fcrerek dikey entegrasyonu takip etmi\u015f, bir sa\u011fl\u0131k ekosistemi yakla\u015f\u0131m\u0131 olu\u015fturmu\u015ftur. Walgreens ise tam sat\u0131n al\u0131mlar yerine ortakl\u0131klar ve yat\u0131r\u0131mlara (VillageMD gibi) odaklanm\u0131\u015f, daha g\u00fc\u00e7l\u00fc bir uluslararas\u0131 varl\u0131k s\u00fcrd\u00fcr\u00fcrken CVS a\u011f\u0131rl\u0131kl\u0131 olarak ABD odakl\u0131 kalm\u0131\u015ft\u0131r."},{"question":"Hangi hisse daha iyi temett\u00fc geliri sunuyor, CVS mi yoksa Walgreens mi?","answer":"Walgreens genellikle CVS'ye (%3,2) k\u0131yasla daha y\u00fcksek bir temett\u00fc getirisi (%4,8 \u015fu anda) sunar. Ancak, CVS daha g\u00fc\u00e7l\u00fc temett\u00fc b\u00fcy\u00fcme potansiyeli ve daha d\u00fc\u015f\u00fck bir \u00f6deme oran\u0131 (%32'ye kar\u015f\u0131 %42) g\u00f6stermi\u015ftir, bu da daha iyi uzun vadeli s\u00fcrd\u00fcr\u00fclebilirlik \u00f6nermektedir. Yat\u0131r\u0131mc\u0131lar hem mevcut getiriyi hem de gelecekteki b\u00fcy\u00fcme potansiyelini dikkate almal\u0131d\u0131r."},{"question":"Hisse senetleri tarihsel olarak birbirlerine kar\u015f\u0131 nas\u0131l performans g\u00f6sterdi?","answer":"Son be\u015f y\u0131lda, CVS hissesi Walgreens'i geride b\u0131rakarak %12'lik bir getiri sa\u011flad\u0131, WBA ise %45'lik bir d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131. CVS, daha d\u00fc\u015f\u00fck volatilite (%22'ye kar\u015f\u0131 %30) ve piyasa d\u00fc\u015f\u00fc\u015flerinden daha iyi toparlanma g\u00f6sterdi, \u00f6zellikle 2020 piyasa bozulmas\u0131 s\u0131ras\u0131nda CVS %14 d\u00fc\u015ferken Walgreens %28 d\u00fc\u015ft\u00fc."},{"question":"CVS ve Walgreens'i bekleyen en b\u00fcy\u00fck riskler nelerdir?","answer":"Her iki \u015firket de ila\u00e7 geri \u00f6deme bask\u0131lar\u0131, \u00e7evrimi\u00e7i eczane rakiplerinden dijital bozulma ve sa\u011fl\u0131k politikas\u0131 belirsizli\u011fi ile kar\u015f\u0131 kar\u015f\u0131ya. CVS, Aetna entegrasyonunun karma\u015f\u0131kl\u0131\u011f\u0131 ve PBM d\u00fczenleyici incelemesi ile ilgili \u00f6zel risklerle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131rken, Walgreens, %68 oran\u0131nda eczane geri \u00f6deme bask\u0131s\u0131na maruz kalmas\u0131 ve ortakl\u0131k y\u00fcr\u00fctme ba\u011f\u0131ml\u0131l\u0131klar\u0131 nedeniyle daha b\u00fcy\u00fck zorluklarla kar\u015f\u0131 kar\u015f\u0131ya."},{"question":"Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri bu eczane hisselerini nas\u0131l etkileyebilir?","answer":"Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri, i\u015f modellerine ba\u011fl\u0131 olarak bu hisseleri farkl\u0131 \u015fekilde etkiler. CVS, Aetna sigorta i\u015fi arac\u0131l\u0131\u011f\u0131yla daha do\u011frudan bir etkiye sahiptir ve bu da hem f\u0131rsatlar (kapsam geni\u015flemesinden %3,5 gelir potansiyeli) hem de riskler (potansiyel Medicare Advantage oran ayarlamalar\u0131) yarat\u0131r. Walgreens, eczane geri \u00f6deme politikalar\u0131ndan daha do\u011frudan etkilenir ve son de\u011fi\u015fikliklerden kaynaklanan %2,1 marj etkisi, CVS'nin PBM operasyonlar\u0131 arac\u0131l\u0131\u011f\u0131yla k\u0131smen telafi edilebilecek %1,5'lik etkisiyle kar\u015f\u0131la\u015ft\u0131r\u0131l\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"CVS ve Walgreens i\u015f modelleri aras\u0131ndaki temel farklar nelerdir?","answer":"CVS, Aetna (sa\u011fl\u0131k sigortas\u0131) sat\u0131n alarak ve g\u00fc\u00e7l\u00fc bir PBM i\u015fini s\u00fcrd\u00fcrerek dikey entegrasyonu takip etmi\u015f, bir sa\u011fl\u0131k ekosistemi yakla\u015f\u0131m\u0131 olu\u015fturmu\u015ftur. Walgreens ise tam sat\u0131n al\u0131mlar yerine ortakl\u0131klar ve yat\u0131r\u0131mlara (VillageMD gibi) odaklanm\u0131\u015f, daha g\u00fc\u00e7l\u00fc bir uluslararas\u0131 varl\u0131k s\u00fcrd\u00fcr\u00fcrken CVS a\u011f\u0131rl\u0131kl\u0131 olarak ABD odakl\u0131 kalm\u0131\u015ft\u0131r."},{"question":"Hangi hisse daha iyi temett\u00fc geliri sunuyor, CVS mi yoksa Walgreens mi?","answer":"Walgreens genellikle CVS'ye (%3,2) k\u0131yasla daha y\u00fcksek bir temett\u00fc getirisi (%4,8 \u015fu anda) sunar. Ancak, CVS daha g\u00fc\u00e7l\u00fc temett\u00fc b\u00fcy\u00fcme potansiyeli ve daha d\u00fc\u015f\u00fck bir \u00f6deme oran\u0131 (%32'ye kar\u015f\u0131 %42) g\u00f6stermi\u015ftir, bu da daha iyi uzun vadeli s\u00fcrd\u00fcr\u00fclebilirlik \u00f6nermektedir. Yat\u0131r\u0131mc\u0131lar hem mevcut getiriyi hem de gelecekteki b\u00fcy\u00fcme potansiyelini dikkate almal\u0131d\u0131r."},{"question":"Hisse senetleri tarihsel olarak birbirlerine kar\u015f\u0131 nas\u0131l performans g\u00f6sterdi?","answer":"Son be\u015f y\u0131lda, CVS hissesi Walgreens'i geride b\u0131rakarak %12'lik bir getiri sa\u011flad\u0131, WBA ise %45'lik bir d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131. CVS, daha d\u00fc\u015f\u00fck volatilite (%22'ye kar\u015f\u0131 %30) ve piyasa d\u00fc\u015f\u00fc\u015flerinden daha iyi toparlanma g\u00f6sterdi, \u00f6zellikle 2020 piyasa bozulmas\u0131 s\u0131ras\u0131nda CVS %14 d\u00fc\u015ferken Walgreens %28 d\u00fc\u015ft\u00fc."},{"question":"CVS ve Walgreens'i bekleyen en b\u00fcy\u00fck riskler nelerdir?","answer":"Her iki \u015firket de ila\u00e7 geri \u00f6deme bask\u0131lar\u0131, \u00e7evrimi\u00e7i eczane rakiplerinden dijital bozulma ve sa\u011fl\u0131k politikas\u0131 belirsizli\u011fi ile kar\u015f\u0131 kar\u015f\u0131ya. CVS, Aetna entegrasyonunun karma\u015f\u0131kl\u0131\u011f\u0131 ve PBM d\u00fczenleyici incelemesi ile ilgili \u00f6zel risklerle kar\u015f\u0131 kar\u015f\u0131ya kal\u0131rken, Walgreens, %68 oran\u0131nda eczane geri \u00f6deme bask\u0131s\u0131na maruz kalmas\u0131 ve ortakl\u0131k y\u00fcr\u00fctme ba\u011f\u0131ml\u0131l\u0131klar\u0131 nedeniyle daha b\u00fcy\u00fck zorluklarla kar\u015f\u0131 kar\u015f\u0131ya."},{"question":"Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri bu eczane hisselerini nas\u0131l etkileyebilir?","answer":"Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri, i\u015f modellerine ba\u011fl\u0131 olarak bu hisseleri farkl\u0131 \u015fekilde etkiler. CVS, Aetna sigorta i\u015fi arac\u0131l\u0131\u011f\u0131yla daha do\u011frudan bir etkiye sahiptir ve bu da hem f\u0131rsatlar (kapsam geni\u015flemesinden %3,5 gelir potansiyeli) hem de riskler (potansiyel Medicare Advantage oran ayarlamalar\u0131) yarat\u0131r. Walgreens, eczane geri \u00f6deme politikalar\u0131ndan daha do\u011frudan etkilenir ve son de\u011fi\u015fikliklerden kaynaklanan %2,1 marj etkisi, CVS'nin PBM operasyonlar\u0131 arac\u0131l\u0131\u011f\u0131yla k\u0131smen telafi edilebilecek %1,5'lik etkisiyle kar\u015f\u0131la\u015ft\u0131r\u0131l\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T13:09:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Tatiana OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatiana OK\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\"},\"author\":{\"name\":\"Tatiana OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"headline\":\"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak\",\"datePublished\":\"2025-07-15T13:09:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\"},\"wordCount\":14,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp\",\"keywords\":[\"investment\",\"stock\",\"strategy\"],\"articleSection\":[\"Reviews\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\",\"name\":\"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp\",\"datePublished\":\"2025-07-15T13:09:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d\",\"name\":\"Tatiana OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g\",\"caption\":\"Tatiana OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/tatiana\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/","og_locale":"tr_TR","og_type":"article","og_title":"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak","og_url":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/","og_site_name":"Pocket Option blog","article_published_time":"2025-07-15T13:09:57+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp","type":"image\/webp"}],"author":"Tatiana OK","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Tatiana OK"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/"},"author":{"name":"Tatiana OK","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"headline":"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak","datePublished":"2025-07-15T13:09:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/"},"wordCount":14,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp","keywords":["investment","stock","strategy"],"articleSection":["Reviews"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/","url":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/","name":"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp","datePublished":"2025-07-15T13:09:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742026952640-855278633-20.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/interesting\/reviews\/cvs-vs-walgreens-stock\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"CVS ve Walgreens Hisse Senetleri: Eczane Devlerinde Yat\u0131r\u0131m Potansiyelini A\u00e7\u0131\u011fa \u00c7\u0131karmak"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/7021606f7d6abf56a4dfe12af297820d","name":"Tatiana OK","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0e5382d258c3e430c69c7fcf955c3ccdee2ae00777d8745ed09f129ffca77c26?s=96&d=mm&r=g","caption":"Tatiana OK"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/tatiana\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":305627,"slug":"cvs-vs-walgreens-stock","post_title":"CVS so v\u1edbi Walgreens Stock: Khai ph\u00e1 Ti\u1ec1m n\u0103ng \u0110\u1ea7u t\u01b0 trong c\u00e1c G\u00e3 kh\u1ed5ng l\u1ed3 Ng\u00e0nh D\u01b0\u1ee3c ph\u1ea9m","href":"https:\/\/pocketoption.com\/blog\/vt\/interesting\/reviews\/cvs-vs-walgreens-stock\/"},"pt_AA":{"locale":"pt_AA","id":305622,"slug":"cvs-vs-walgreens-stock","post_title":"CVS vs Walgreens Stock: Desbloqueando o Potencial de Investimento em Gigantes da Farm\u00e1cia","href":"https:\/\/pocketoption.com\/blog\/pt\/interesting\/reviews\/cvs-vs-walgreens-stock\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/305625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=305625"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/305625\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/220418"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=305625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=305625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=305625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}